 et al 1455

ACCP guidelines,24 with careful attention to the possibility
of heparin-induced thrombocytopenia or malignancy.61
Although the evidence is of low quality and largely
limited to case reports and series, thrombolytic therapy
does appear to limit the progression of pregangrenous
changes in patients with profound iliofemoral venous outflow obstruction. Several reports document the efficacy of
pharmacome